NCT04235920View on ClinicalTrials.gov

Cognitive Impairment and Outcome of Acute Ischemic Stroke.

CompletedOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

October 1, 2017

Primary Completion Date

January 31, 2019

Study Completion Date

March 31, 2019

Conditions

Ischemic StrokeCognitive ImpairmentOutcome, Fatal

Interventions

DIAGNOSTIC_TEST

Montreal Cognitive Assessment (MoCA)

This scale evaluates different domains of cognition like attention, orientation, memory, language, visuoconstructional capacities, and lastly, executive functions. MoCA is a thirty point test with a score of 25 or less considered as abnormal impaired cognition

Trial Locations (1)

35516

Mansoura University Hospital, Al Mansurah

All Listed Sponsors

lead

Mansoura University Hospital

OTHER

NCT04235920 - Cognitive Impairment and Outcome of Acute Ischemic Stroke. | Biotech Hunter | Biotech Hunter